Search
CNS Pharmaceuticals Inc
CNSPAdd to Watchlist
5.110USD
-0.010-0.20%
Close 09-18 16:00（ET）
7.47MMarket Cap
LossP/E TTM
CNSP Financials
See CNS Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
7.47M
Dividend TTM
0.00
P/E TTM
-0.21
EPS TTM
-24.12
Revenue
--
Net Profit
-14.86M
ROE
-298.64%
ROA
-179.17%
CNS Pharmaceuticals Inc Earnings Date
Latest Release
Aug 12, 2026
EPS / Forecast
-0.38/-0.24
Revenue / Forecast
--/0.00
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2025 earnings report, its current assets were 8.10M, with a year-on-year change of -6.42.
What are the total assets of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2025 earnings report, its total assets of CNS Pharmaceuticals Inc were 8.62M, with a year-on-year change of -0.89.
What are the total liabilities of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of CNS Pharmaceuticals Inc were 4.10M, with a year-on-year change of 62.46.
What is the total equity of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2025 earnings report, its total equity of CNS Pharmaceuticals Inc was 4.52M, with a year-on-year change of -26.78.
What is the net operating income of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2025 earnings report, its net operating income of CNS Pharmaceuticals Inc was -15.99M, with a year-on-year change of -7.28.
What is the net investment of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2025 earnings report, its net investment of CNS Pharmaceuticals Inc was -18.18K, with a year-on-year change of -333.98.
What is the net financing of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2025 earnings report, its net financing of CNS Pharmaceuticals Inc was 14.57M, with a year-on-year change of -36.74.
What is the Earnings Per Share (EPS) of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -35.75, with a year-on-year change of 92.34.
What is the net income of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2025 earnings report, its net income was -15.85M, with a year-on-year change of -6.68.
What is the debt-to-asset ratio of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 3.81, with a year-on-year change of 1.67.
What is the Return on Equity (ROE) of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -296.30, with a year-on-year change of 82.61.
What is the Return on Assets (ROA) of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -182.99, with a year-on-year change of 35.95.
What is the operating profit of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -15.99M, with a year-on-year change of -7.28.